Brain1

[WP-14-1] Impact of differentiating pharmacogenous versus true parkinsonism by I-123-ioflupane

Pipitsa Valsamaki¹、Aikaterini Arvaniti ²、Aikaterini Terzoudi ³、Eleni Mavraki ³、Christina Tsigalou⁵、Athanassios Zissimopoulos ¹ (1.Nuclear Medicine Department, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Greece、2.Psychiatry Department, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Greece 、3.Neurology Clinic, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Greece、4.Microbiology Laboratory, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Greece、5.Nuclear Medicine Department, School of Medicine, Democritus University of Thrace, University General Hospital of Alexandroupolis, Greece)